Cancer biology at EACR 2027

Jun 14–17, 2027 Bilbao, Spain ~2.4k attendees Website

19 organizations at EACR 2027 present work in cancer initiation, signalling, metabolism, plasticity and metastasis, led by universities and institutes. Between them they bring 26 presentations to the program. Most represented: Gustave Roussy, Spanish National Cancer Research Centre (CNIO) and ETH Zurich. As of Oct 13, 2026.

All 104 organizations at EACR 2027 →

Showing 1–17 of 19 organizations

Organization	EACR 2027 Attendance
Gustave Roussy Villejuif, France
gustaveroussy.fr Cancer centres & hospitals Cancer hospital and research centre in Villejuif, near Paris, affiliated with Paris-Saclay University.	Talk Tue Jun 15 9:20–10:55am Part of Joint EACR-ASEICA Symposium: Cancer initiation Title to be announced Cancer biology Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Epigenetics and RNA regulation in cancer Harnessing genetic and epitranscriptomic vulnerabilities in cancer: ADAR1 targeting as a new therapeutic opportunity Genomics · Therapy & resistance Talk Tue Jun 15 5:30–6:15pm Part of Keynote Lecture Title to be announced
Spanish National Cancer Research Centre (CNIO) Madrid, Spain
cnio.es Universities & institutes Spain's public cancer research centre, with basic research, translational programmes and an experimental therapeutics programme.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer and extrinsic influences Timely Programs in the Tumor Microenvironment of Lung Cancers Immunology Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Title to be announced Cancer biology Talk Thu Jun 17 9:45–11am Part of EACR-ESMO bench to bedside Plenary Session: Precision targeting of RAS-driven cancers - New biology, new therapies A triple therapy to target pancreatic cancer Therapy & resistance
ETH Zurich Zurich, Switzerland
ethz.ch Universities & institutes Federal institute of technology and research university in Zurich.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Title to be announced Models Plenary Thu Jun 17 11:20am–12:05pm Circulating Tumor Cell Clusters Cancer biology
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Cancer centres & hospitals NCI-designated comprehensive cancer centre in New York City for cancer care and research.	Talk Mon Jun 14 2:25–2:50pm Part of Joint EACR-EACS-Molecular Oncology Session: Latest advances in cancer immune-based therapies Title to be announced Immunology Plenary Mon Jun 14 3:50–6:15pm Part of EACR 2027 Congress - Opening Session Opening Keynote Lecture: Targeting Dormant Metastasis Cancer biology · Therapy & resistance
Research Institute of Molecular Pathology (IMP) Vienna, Austria
imp.ac.at Universities & institutes Basic biomedical research institute at the Vienna BioCenter in Austria, largely funded by Boehringer Ingelheim.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Decoding tumor dependencies through in-vivo CRISPR screens Models · Genomics Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer plasticity, metastasis, and therapy resistance Title to be announced Cancer biology · Therapy & resistance
University of Cambridge Cambridge, UK
cam.ac.uk Universities & institutes Public research university in Cambridge, UK, with a clinical school and cancer and stem cell research institutes.	Talk Tue Jun 15 9:20–10:55am Part of Joint EACR-ASEICA Symposium: Cancer initiation Fate versus Free will; how does the environment shape early tumour survival? Cancer biology Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Cancer prevention and genomic instability / Epidemiology and molecular evidence to inform cancer prevention Decoding the earliest steps of BRCA-driven breast tumour initiation: towards rational prevention Prevention & detection
University College London (UCL) London, UK
ucl.ac.uk Universities & institutes Public research university in London, home to the UCL Cancer Institute.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Pharmacological activation of PI3Kα induces cancer cell death under metabolic stress Cancer biology · Therapy & resistance
Cancer Research Center of Toulouse (CRCT) Toulouse, France
crct-inserm.fr Universities & institutes Cancer research centre in Toulouse, France, run by Inserm, CNRS and the University of Toulouse.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer PI3Ks & Cancerogenesis: mechanical context matters Cancer biology
CIC bioGUNE Derio, Spain
cicbiogune.es Universities & institutes Biomedical research centre in the Bizkaia Science and Technology Park near Bilbao, Spain.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Metabolic deregulation in cancer Title to be announced Cancer biology
Hospital del Mar Research Institute Barcelona, Spain
researchmar.net Universities & institutes Biomedical research institute linked to Hospital del Mar in Barcelona, Spain, with a cancer research programme.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer plasticity, metastasis, and therapy resistance Targeting immune-evasive cell states in cancer metastasis Immunology · Cancer biology
IFOM (AIRC Institute of Molecular Oncology) Milan, Italy
ifom.eu Universities & institutes Molecular oncology research institute in Milan, Italy, supported by the Italian cancer research foundation AIRC.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Oncogenic signaling beyond cancer Deciphering the Hidden Molecular and Spatial Code of Metastasis Cancer biology · Genomics
Ikerbasque Bilbao, Spain
ikerbasque.net Societies, charities & agencies Basque Foundation for Science, which recruits and funds researchers working at universities and research centres in the Basque Country.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Bioengineering Models for Breast Cancer Dormancy and Early Metastasis Models · Cancer biology
Josep Carreras Leukaemia Research Institute Badalona, Spain
carrerasresearch.org Universities & institutes Research institute near Barcelona devoted to leukaemia and other blood cancers and diseases.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Oncogenic signaling beyond cancer Aberrant PI3K in vascular malformations Cancer biology
KU Leuven Leuven, Belgium
kuleuven.be Universities & institutes Research university in Leuven, Belgium.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Metabolic deregulation in cancer Unraveling T cell metabolism across functional states in the tumor microenvironment Immunology · Cancer biology
Lund University Lund, Sweden
lu.se Universities & institutes Public research university in Lund, Sweden; its Lund University Cancer Centre (LUCC) brings together cancer research groups.	Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Tumor microenvironment Microenvironmental control of malignant phenotypes Immunology · Cancer biology
NYU Langone Health New York, NY
nyulangone.org Cancer centres & hospitals Academic medical center and health system based in New York City.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Oncogenic signaling beyond cancer Targeting PI3K in overgrowth syndromes Cancer biology · Therapy & resistance
University of Würzburg Würzburg, Germany
uni-wuerzburg.de Universities & institutes Public research university in Würzburg, Germany; its Biozentrum houses life sciences research groups.	Talk Wed Jun 16 3:20–4:55pm Part of Symposium: Revisiting MYC How MYC proteins enable tumours to hide from the immune system Cancer biology · Immunology